You have no items in your shopping cart.
Recombinant HER2 Fab Antibody
Description
Images & Validation
−| Tested Applications | ELISA, FC, WB |
|---|---|
| Dilution range | ELISA: 1:10,000 to 1:100,000, FC: 1:100, WB: 1:2,000 |
| Reactivity | Human |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Clonality | Recombinant |
| Isotype | IgG Fab |
| Clone No. | Abz518 |
| Source/Expression System | E. coli |
| Purity | Humanized Recombinant HER2 Fab fragment was expressed in E. coli cells. The purity was estimated to be > 90% by SDS-PAGE analysis. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Store vial at 2-8° C. Dilute only prior to immediate use. |
|---|---|
| Form/Appearance | Liquid (sterile filtered) |
| Buffer/Preservatives | Preservative: 0.01% (w/v) Sodium Azide. Stabilizer: 30% Glycerol; Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| Concentration | 0.59 mg/ml |
| Disclaimer | For research use only |
Alternative Names
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

ELISA results show the sensitivity of Humanized Recombinant Anti-human HER2 Fab fragment Antibody tested against purified HER2 protein. Each well was coated in duplicate with 1.0 µg of HER2. The starting dilution of antibody was 5.0 µg/ml.

Flow Cytometry of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Primary Antibody: Recombinant Anti-HER2 Fab fragment (red line) recognizes HER2 on SK-OV-3 cells while using Anti-human kappa FITC secondary antibody at 0.2 µl with a 56.8% positive cells. Controls used: (black line) no primary antibody, no secondary antibody, 0.6%; (green line) no primary antibody, Anti-human kappa FITC secondary antibody at 0.2 µl, 1.0%.

SDS-PAGE of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Lane 1: Molecular Weight Ladder. Lane 2: reduced recombinant HER2 Fab fragment. Lane 3: non-reduced recombinant HER2 Fab fragment.

Western Blot of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Lane 1 and 8: Molecular Weight Marker. Lane 2 and 6: 0.02 µg HER2. Lane 3 and 7: 20 µg non-spiked SKOV-3 lysate. Lane 4 and 9: 20 µg SKOV-3 lysate spiked with 0.05 µg HER2. Lane 5 and 10: 20 µg SKOV-3 lysate spiked with 0.02 µg HER2. Primary Antibody: Anti-HER2 Fab incubated with lanes 1-5 only. Secondatry Antibody: Anti-F(ab)'2 HRP conjugate at 1:5000. Anti-HER2 Fab antibody observed in native HER2 and spiked HER2 in SKOV-3 cell lysates.

Western Blot of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Lane 1: Molecular Weight Ladder. Lane 2, 5, and 8: Empty. Lane 3, 6, and 9: HER2 reduced. Lane 4, 7, 10: HER2 non-reduced. Protein Load: Lane 3-4: 0.5 µg. Lane 6-7: 0.1 µg. Lane 9-10: 0.02 µg. Primary Antibody: anti-HER2 Fab at 1:2000 for 2 hours at 4°C. Secondary Antibody: Anti-human kappa FITC conjugate at 1:1000 for 2 hours at 4°C. Exposure time 60s.
Quick Database Links
UniProt Details
−NCBI Reference Sequences
−| Protein | NP_001005862.1 |
|---|
Documents Download
Request a Document
Protocol Information
Recombinant HER2 Fab Antibody (orb420301)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review